Abstract
Monitoring disease activity in a complex, heterogeneous disease such as lupus is difficult. Both over- and undertreatment lead to damage. Current standard of care serologies are unreliable. Better measures of disease activity are necessary as we move into the era of precision medicine. We show here the use of a data-driven, modular approach to genomic biomarker development within lupus - specifically lupus nephritis.
Original language | English |
---|---|
Article number | 7862962 |
Journal | International Journal of Genomics |
Volume | 2016 |
Early online date | 01 Aug 2016 |
DOIs | |
Publication status | Early online date - 01 Aug 2016 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Genetics
- Pharmaceutical Science